Figure 1From: Robustness of the healthcare utilization results from the Rotavirus Efficacy and Safety Trial (REST) evaluating the human-bovine (WC3) reassortant pentavalent rotavirus vaccine (RV5) REST Study Design with Respect to the Collection of the Healthcare Utilization Data. N = number vaccinated.Back to article page